Knowledge Hub

Insight of Current and Future Market for Natural Killer Cells - Competitive Landscape, Pipeline and Market Analysis, 2017

Press Release   •   Feb 23, 2017 05:24 EST

DelveInsights, Natural Killer Cells- Competitive Landscape, Pipeline and Market Analysis, 2017, report provides comprehensive insights about marketed and pipeline drugs across this Mechanism of action. Key objective of the report is to establish the understanding for all the marketed and pipeline drugs that fall under Natural Killer Cells.

This report provides information on the therapeutic development based on Natural Killer Cells mechanism of action dealing with around 20+ active pipeline drugs. Report covers the product clinical trials information and other development activities including technology, licensing, collaborations, acquisitions, fundings, patent and USFDA & EMA designations details. Report contains the development and sale activities for marketed drugs. DelveInsights Report also assesses the Natural Killer Cells therapeutics by Monotherapy, Combination products, Molecule type and Route of Administration. The report also covers the information for 20+ active companies involved in the therapeutic development of the products.

View Report @


  • The report provides competitive pipeline landscape of Natural Killer Cells
  • The report provides the marketed drugs information including its sales, development activities and details of patent expiry
  • The report provides the insight of current and future market for Natural Killer Cells
  • The report provides pipeline products under drug profile section which includes product description, MOA, licensors & collaborators, development partner and chemical information
  • Coverage of the Natural Killer Cells pipeline on the basis of target, MOA, route of administration, technology involved and molecule type
  • The report reviews key players involved in the therapeutics development for Natural Killer Cells and also provide company profiling
  • The report also gives the information of dormant pipeline projects
  • Pipeline products coverage based on various stages of development ranging from preregistration till discovery and undisclosed stages
  • Provides pipeline assessment by monotherapy and combination therapy products, stage of development and molecule type

Get Sample Copy Of This Report @

Reasons to Buy

  • Identify emerging players with potentially strong product information and create effective counter-strategies to gain competitive advantage
  • Complete MOA intelligence and complete understanding over therapeutics development for Natural Killer Cells
  • Identify the relationship between the drugs and use it for target finding, drug repurposing, and precision medicine.
  • Devise corrective measures for pipeline projects by understanding Natural Killer Cells pipeline depth and focus of Indication therapeutics
  • Developing strategic initiatives to support your drug development activities.
  • Optimize your portfolio and keep you in touch with the rapidly changing pharmaceutical markets, and make the best decisions for your business.
  • Develop and design in licensing and out licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
  • Provides strategically significant competitor information, analysis, and insights to formulate effective R&D development strategies
  • Modify the therapeutic portfolio by identifying discontinued projects and understanding the factors that drove them from pipeline
  • Gaining a Full Picture of the Competitive Landscape for Evidence based Decisions

Table of Contents

Executive Summary Snapshot Report

Executive Summary

Natural Killer Cells Overview

Analysis of NK cells based therapies

NK Cells Receptors and Shares

Percentage Share of NK Cell Based Therapeutics

Targets of Natural Killer Cells Based Therapies and Their Analysis

NK Cells Based Therapy Collaborations

Collaborations and Deal Year

Collaborations and Deal value

Licensing Agreement for future development of NK Cell Therapy

Financing details of NK cells based therapies

Companies received Grants for NK cells based therapies


Institutes involved in NK cells based therapies

Technologies Involved in NK Cells Based Therapies

Clinical trials & Completion Year

Phase III Drugs

Phase II Drugs

Phase I Drugs

Recent Trends in NK Cells Therapy

Leading Companies and their Shares in Natural Killer cells Therapeutics

Market Drivers

Market Barriers

SWOT Analysis

Pipeline Therapeutics

Therapeutics under Development by Companies

Late Stage Products (Phase III)

Comparative Analysis

Mid Stage Products (Phase II)

Comparative Analysis is the most comprehensive collection of market research reports. MarketResearchReports.Biz services are specially designed to save time and money for our clients. We are a one stop solution for all your research needs, our main offerings are syndicated research reports, custom research, subscription access and consulting services. We serve all sizes and types of companies spanning across various industries.